| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12013-017-0785-6 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s12013-017-0785-6 |
| P698 | PubMed publication ID | 28281231 |
| P50 | author | Vladimir N. Uversky | Q59698496 |
| P2093 | author name string | Eugene A Permyakov | |
| Sergei E Permyakov | |||
| Ekaterina A Litus | |||
| P2860 | cites work | Mutations and polymorphisms of the gene of the major human blood protein, serum albumin | Q46610261 |
| Evaluation of drug-human serum albumin binding interactions with support vector machine aided online automated docking | Q47375940 | ||
| Binding of calcium to serum albumin. III. Influence of ionic strength and ionic medium | Q47764836 | ||
| Multi-metal binding site of serum albumin | Q47856742 | ||
| A spectroscopic study of the haemin--human-serum-albumin system | Q47884314 | ||
| X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution | Q48112902 | ||
| Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. | Q48682040 | ||
| Comprehensive comparative assessment of in-silico predictors of disordered regions. | Q51506846 | ||
| The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. | Q52974739 | ||
| Transition metal complexes of 2, 6-di ((phenazonyl-4-imino) methyl)-4-methylphenol: structure and biological evaluation. | Q53263520 | ||
| Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases. | Q53820168 | ||
| Accurate prediction of disorder in protein chains with a comprehensive and empirically designed consensus | Q56992931 | ||
| Glucose Modification of Human Serum Albumin: A Structural Study | Q58212783 | ||
| Intrinsically disordered proteins and intrinsically disordered protein regions | Q38194194 | ||
| Introducing protein intrinsic disorder | Q38205058 | ||
| Crystal structural analysis of human serum albumin complexed with hemin and fatty acid | Q21256430 | ||
| Intrinsically Disordered Proteins in Human Diseases: Introducing the D 2 Concept | Q22061726 | ||
| Classification of intrinsically disordered regions and proteins | Q22061736 | ||
| Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures | Q24273429 | ||
| Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites | Q24311737 | ||
| Structural basis of the drug-binding specificity of human serum albumin | Q24324365 | ||
| Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms | Q24548466 | ||
| The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 | ||
| Cubilin is an albumin binding protein important for renal tubular albumin reabsorption | Q24618773 | ||
| The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan | Q24673691 | ||
| SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix | Q24679549 | ||
| Albumin-based drug delivery: harnessing nature to cure disease | Q26765789 | ||
| Review: modifications of human serum albumin and their binding effect | Q26829605 | ||
| Recent topics in chemical and clinical research on glycated albumin | Q26865088 | ||
| Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators | Q27000495 | ||
| Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker | Q27012452 | ||
| Crystal structure of human serum albumin at 2.5 A resolution | Q27618893 | ||
| Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin | Q27627815 | ||
| Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I | Q27630983 | ||
| Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids | Q27636833 | ||
| The atomic structure of human methemalbumin at 1.9 A | Q27638056 | ||
| A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions | Q27664673 | ||
| Structural Mechanism of Ring-opening Reaction of Glucose by Human Serum Albumin | Q27677418 | ||
| Structural and immunologic characterization of bovine, horse, and rabbit serum albumins | Q27679534 | ||
| Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms | Q27681475 | ||
| Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface | Q27687134 | ||
| Discovery and characterization of an endogenous CXCR4 antagonist | Q27700279 | ||
| Glycated Serum Albumin and AGE Receptors | Q38608171 | ||
| Bovine Serum Albumin Interactions with Metal Complexes | Q38623221 | ||
| Dancing Protein Clouds: The Strange Biology and Chaotic Physics of Intrinsically Disordered Proteins | Q38724766 | ||
| Fatty Acid-Mediated Inhibition of Metal Binding to the Multi-Metal Site on Serum Albumin: Implications for Cardiovascular Disease. | Q38735509 | ||
| Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration Studies | Q38800607 | ||
| Interaction between glycated serum albumin and AGE-receptors depends on structural changes and the glycation reagent | Q39256789 | ||
| Albumin--an important extracellular antioxidant? | Q39628687 | ||
| Serum albumin | Q39635797 | ||
| Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation | Q40013361 | ||
| S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties | Q40202863 | ||
| Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks | Q41884066 | ||
| Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model | Q41888176 | ||
| PrDOS: prediction of disordered protein regions from amino acid sequence | Q42431942 | ||
| The structural and functional signatures of proteins that undergo multiple events of post-translational modification | Q42663688 | ||
| Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia | Q43512400 | ||
| Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. | Q43619593 | ||
| Albumin is the major plasma protein target of oxidant stress in uremia | Q43651261 | ||
| Effect of oxidative stress on the structure and function of human serum albumin | Q43682869 | ||
| Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses | Q44193411 | ||
| How do fatty acids cause allosteric binding of drugs to human serum albumin? | Q44211826 | ||
| ESpritz: accurate and fast prediction of protein disorder | Q44385437 | ||
| Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite | Q44553269 | ||
| Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin. | Q44966520 | ||
| Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin | Q45094565 | ||
| Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity | Q45158697 | ||
| Update on the cellular and molecular basis of capillary permeability | Q46216913 | ||
| Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin | Q46473684 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| Functional roles of transiently and intrinsically disordered regions within proteins | Q28085662 | ||
| Intrinsically disordered protein | Q28191444 | ||
| The antioxidant properties of serum albumin | Q28279790 | ||
| Atomic structure and chemistry of human serum albumin | Q28283217 | ||
| Oxidative mechanisms in the toxicity of metal ions | Q28301127 | ||
| Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues? | Q28306054 | ||
| Fatty acid binding to human serum albumin: new insights from crystallographic studies | Q28376781 | ||
| A decade and a half of protein intrinsic disorder: biology still waits for physics | Q28681184 | ||
| The importance of intrinsic disorder for protein phosphorylation | Q28776125 | ||
| Intrinsically unstructured proteins | Q29614784 | ||
| Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm | Q29615865 | ||
| IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content | Q29615888 | ||
| Intrinsic disorder and protein function | Q29616415 | ||
| Natively unfolded proteins: a point where biology waits for physics | Q29616416 | ||
| Sequence complexity of disordered protein | Q29616420 | ||
| Exploiting heterogeneous sequence properties improves prediction of protein disorder. | Q30351476 | ||
| Length-dependent prediction of protein intrinsic disorder. | Q30353929 | ||
| Understanding protein non-folding. | Q30385084 | ||
| Intrinsically disordered proteins: a 10-year recap | Q30421421 | ||
| S-nitrosylation signaling in cell biology | Q30433042 | ||
| Relaxometric characterization of human hemalbumin. | Q30657242 | ||
| Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study | Q30666587 | ||
| Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization | Q31004362 | ||
| Reactivity of sulfenic acid in human serum albumin | Q33310193 | ||
| Dehydroalanine derived from cysteine is a common post-translational modification in human serum albumin | Q33319233 | ||
| Allergy to mammalian proteins: at the borderline between foreign and self? | Q33820686 | ||
| PONDR-FIT: a meta-predictor of intrinsically disordered amino acids | Q33902242 | ||
| Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. | Q33907748 | ||
| Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases | Q33909288 | ||
| A method for simultaneous alignment of multiple protein structures | Q33978603 | ||
| Unraveling the mysteries of serum albumin-more than just a serum protein. | Q34030577 | ||
| Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study. | Q34184956 | ||
| Antioxidants in health and disease. | Q34186079 | ||
| Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy | Q34212667 | ||
| D²P²: database of disordered protein predictions | Q34314929 | ||
| FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded | Q34426417 | ||
| What does it mean to be natively unfolded? | Q34488954 | ||
| Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. | Q34702948 | ||
| Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance | Q34782503 | ||
| Interdomain zinc site on human albumin | Q34915559 | ||
| Identification and functions of usefully disordered proteins | Q34989882 | ||
| Protein folding revisited. A polypeptide chain at the folding ? misfolding ? nonfolding cross-roads: which way to go? | Q35549177 | ||
| Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. | Q35683493 | ||
| Extracellular thiols and thiol/disulfide redox in metabolism | Q35799916 | ||
| Serum Glycated Albumin to Guide the Diagnosis of Diabetes Mellitus | Q35893821 | ||
| Albumin: biochemical properties and therapeutic potential | Q36138540 | ||
| Identification of albumin-binding proteins in capillary endothelial cells | Q36219028 | ||
| Interactions of myristic acid with bovine serum albumin: a 13C NMR study. | Q36262660 | ||
| The extraordinary ligand binding properties of human serum albumin | Q36360733 | ||
| PDBFlex: exploring flexibility in protein structures | Q36435012 | ||
| Perspective-- FcRn transports albumin: relevance to immunology and medicine | Q36491130 | ||
| Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties | Q36807461 | ||
| Anticancer carrier-linked prodrugs in clinical trials | Q36861603 | ||
| FcRn: the neonatal Fc receptor comes of age. | Q36912134 | ||
| Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin | Q37159291 | ||
| TOP-IDP-scale: a new amino acid scale measuring propensity for intrinsic disorder | Q37178764 | ||
| Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles | Q37201079 | ||
| High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway | Q37215654 | ||
| Review: Glycation of human serum albumin | Q37227387 | ||
| Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. | Q37330432 | ||
| Pharmaceutically important pre- and posttranslational modifications on human serum albumin. | Q37428486 | ||
| Lessons from the crystallographic analysis of small molecule binding to human serum albumin | Q37595256 | ||
| Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization. | Q37601322 | ||
| Glycation research in amino acids: a place to call home | Q37803550 | ||
| Specific antioxidant properties of human serum albumin | Q38082001 | ||
| Albumin as a versatile platform for drug half-life extension | Q38103725 | ||
| Alternative splicing of intrinsically disordered regions and rewiring of protein interactions | Q38109334 | ||
| Interactive association of drugs binding to human serum albumin | Q38192435 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-03-10 | |
| P1433 | published in | Cell Biochemistry and Biophysics | Q15755135 |
| P1476 | title | Intrinsically Disordered Regions in Serum Albumin: What Are They For? |
| Q38671267 | Diagnosing allergic sensitizations in the third millennium: why clinicians should know allergen molecule structures | cites work | P2860 |
Search more.